DGX
$152.65
Quest Diagnostics
$1.45
.96%
DGX
Earnings Whisper ®
N/A
4th Quarter December 2024
Consensus:  $2.19
Revenue:  $2.57 Bil
Thursday
Jan 30
6:45 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when DGX reports earnings?
Beat
Meet
Miss

Where is DGX's stock price going from here?
Up
Flat
Down
Stock chart of DGX
Analysts
Summary of analysts' recommendations for DGX
Score
Grade
Pivots
Resistance
$155.30
$154.44
$152.82

$151.96

Support
$150.34
$149.48
$147.86
Tweet
Growth
Description
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Peers
Laboratory Corp. of America